课题基金 / 基金详情

Heme oxygenases, intrinsic defense system, as a novel therapeutic target for atherosclerotic disorders

Heme oxygenases, intrinsic defense system, as a novel therapeutic target for atherosclerotic disorders
血红素加氧酶,内在防御系统,作为动脉粥样硬化疾病的新型治疗靶点
批准号:
14570682
负责人:
ISHIKAWA Kazunobu
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

ISHIKAWA Kazunobu的其他基金

相似基金

相关文献

中文摘要
翻译
血红素加氧酶(HO)是血红素降解所必需的酶,在各种病理生理条件下通过产生胆汁色素、一氧化碳(CO)和铁蛋白而显示出抗氧化和抗炎特性。最近的一些研究表明HO反应在心血管疾病中具有生物学效应。HO是一种可诱导的HO,H 0 -1是由氧化脂蛋白、细胞因子、血流动力学变化、血管紧张素II和一氧化氮(NO)等多种应激因素诱导产生的。在此期间,我们观察到,H 0 -1诱导似乎是对这些有害刺激的适应性反应。动脉壁H 0 -1诱导清除活性氧,导致单核细胞粘附和趋化性减弱。H 0 -1诱导还减少血浆和动脉壁中的脂质过氧化。H 0 -1的这些性质表明这种酶的抗动脉粥样硬化作用。我们还研究了内皮细胞H 0 -1表达和胆红素在动脉粥样硬化形成中的作用。HO-1似乎也在血管成形术后再狭窄中发挥重要作用,再狭窄是与动脉粥样硬化相关的主要临床问题。作为临床研究,我们观察了急性心肌梗死患者血清中生物吡啉水平的变化。人类HO-1遗传学支持这些实验结果。我们目前正在继续研究,这将解决目前各种心血管疾病的问题。
英文摘要
Heme oxygenase (HO), an enzyme essential for heme degradation, shows anti-oxidative and anti-inflammatory properties via the production of bile pigmehts, carbon monoxide (CO) and ferritin induction under various pathophysiological conditions. A number of recent studies have shown biological effects of HO reaction in cardiovascular disorders. An inducible form of HO, H0-1, is induced by a variety of stresses such as oxidized lipoproteins, cytokines, hemodynamic changes, angiotensin II and nitric oxide (NO) in vascular wall. In this grant period, we observed that H0-1 induction seems to function as an adaptive response against these injurious stimuli. H0-1 induction in artery wall scavenged reactive oxygen species, which leads to the attenuation of monocyte adhesion and chemotaxis. H0-1 induction also reduces lipid peroxidation in plasma and artery wall. These properties of H0-1 suggest anti-atherogenic roles of this enzyme. We also examined the roles of endothelial H0-1 expression and bilirubin in atherogenesis. HO-1 also seems to play a significant role in restenosis after angioplasty, which is a major clinical problem associated with atherosclerosis. As a clinical research, we investigated the changes of the levels of biopyrrins in the patients with acute myocardial infarction. human HO-1 genetics supports these experimental results. We are currently continuing the research, which will solve current problems in various cardiovascular disorders.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
Ishikawa K: "Heme oxygenase-1 against vascular insufficiency : Roles of atherosclerotic disorders"Current Pharmaceutical Design. 9. 2489-2497 (2003)
Ishikawa K:“血红素加氧酶-1 对抗血管功能不全:动脉粥样硬化性疾病的作用”当前的药物设计。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ishikawa, K: "Heme oxygenase-1 against vascular insufficiency : Roles of atherosclerotic disorders."Current Pharmaceutical Design.. 9. 2489-2497 (2003)
Ishikawa, K:“血红素加氧酶-1 对抗血管功能不全:动脉粥样硬化性疾病的作用。”当前药物设计.. 9. 2489-2497 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ishikawa K.: "Heme oxygenase-1 against vascular insufficiency : Roles of atherosclerotic disorders."Current Pharmaceutical Design. 9. 2489-2497 (2003)
Ishikawa K.:“血红素加氧酶-1 对抗血管功能不全:动脉粥样硬化性疾病的作用。”当前的药物设计。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ishikawa, K: "Anti-atherogenic properties of heme oxygenase. In Heme oxygenase in Biology and Medicine"Kluwer Academic / Plenum Publishers, New York, USA. 8(293-301) (2002)
Ishikawa, K:“血红素加氧酶的抗动脉粥样硬化特性。在生物学和医学中的血红素加氧酶”Kluwer Academy / Plenum Publishers,纽约,美国。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 15 条
    Study on clinical implication of sarcopenia in cardiovascular disorders
    • 批准号:
      24590893
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2012
    • 负责人:
      ISHIKAWA Kazunobu
    • 依托单位:
    ANALYSES OF ANTI-ATHEROGENIC PROPERTIES OF HEME OXYGENASE-1
    • 批准号:
      12670683
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2000
    • 负责人:
      ISHIKAWA Kazunobu
    • 依托单位:
    Mechanism of targeting and transport of mitochondrial precursor proteins to mitochondria
    • 批准号:
      04670135
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1992
    • 负责人:
      ISHIKAWA Kazunobu
    • 依托单位:
    国内基金
    海外基金
    卡路里限制的T细胞糖脂代谢重塑机制及网络调控
    • 批准号:
      91957111
    • 项目类别:
      重大研究计划
    • 资助金额:
      80.0万元
    • 批准年份:
      2019
    • 负责人:
      李佩盈
    • 依托单位:
    高尿酸血症促进动脉粥样硬化机制探讨
    • 批准号:
      81170251
    • 项目类别:
      面上项目
    • 资助金额:
      14.0万元
    • 批准年份:
      2011
    • 负责人:
      刘梅林
    • 依托单位:
    磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
    • 批准号:
      81070247
    • 项目类别:
      面上项目
    • 资助金额:
      33.0万元
    • 批准年份:
      2010
    • 负责人:
      秦树存
    • 依托单位:
    大麻素CB2受体:巨噬细胞efferocytosis功能调控和不稳定斑块防治的新靶点
    • 批准号:
      81000086
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2010
    • 负责人:
      江立生
    • 依托单位: